FEATURES OF DIAGNOSIS AND TREATMENT OF PROSTATE CANCER IN PATIENTS WITH COMORBID PATHOLOGY: CURRENT STATE OF THE PROBLEM
;
prostate cancer, comorbidity, diagnosis, treatment, cardiovascular diseases, diabetes mellitus, personalized medicine.Abstrak
Prostate cancer (PCa) remains one of the most common malignant neoplasms among men worldwide. Due to population aging, the prevalence of concomitant chronic diseases among patients diagnosed with prostate cancer is steadily increasing. Cardiovascular diseases, diabetes mellitus, obesity, chronic kidney disease, and respiratory disorders significantly influence diagnostic accuracy, treatment selection, oncological outcomes, and quality of life. The presence of comorbidity complicates decision-making and requires an individualized multidisciplinary approach. This review analyzes current evidence regarding the impact of comorbid conditions on prostate cancer diagnosis and treatment and discusses strategies aimed at improving outcomes in this patient population.
Iqtiboslar
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2025.
Sung H et al. Global Cancer Statistics 2024.
Mottet N et al. EAU Guidelines on Prostate Cancer. 2025.
Mohler JL et al. NCCN Clinical Practice Guidelines in Prostate Cancer. 2025.
Charlson ME et al. A New Method of Classifying Prognostic Comorbidity.
D'Amico AV et al. Risk Stratification in Prostate Cancer.
Nguyen PL et al. Cardiovascular Effects of Androgen Deprivation Therapy.
Bosco C et al. Metabolic Consequences of ADT.
Keating NL et al. Diabetes and Prostate Cancer Outcomes.
Van Hemelrijck M et al. Comorbidity and Prostate Cancer Survival.
Hamdy FC et al. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy.
Ahmed HU et al. Diagnostic Accuracy of Multiparametric MRI.
Hofman MS et al. PSMA PET Imaging in Prostate Cancer.
Droz JP et al. Management of Prostate Cancer in Older Patients.
Resnick MJ et al. Long-Term Functional Outcomes after Treatment.
##submission.downloads##
Nashr qilingan
Nashr
Bo'lim
Iqtibos keltirish tartibi
